The leading multination pharmaceutical company plans to use ArisGlobal’s platform to deliver the next generation of integrated signal detection and risk management globally. Miami, FL January 21, 2021 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives, has […]
The post Dr. Reddy’s Laboratories Selects LifeSphere® Signal and Risk Management appeared first on ArisGlobal.